Combination of a Proteomics Approach and Reengineering of Meso Scale Network Models for Prediction of Mode-of-Action for Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

Combination of a Proteomics Approach and Reengineering of Meso Scale Network Models for Prediction of Mode-of-Action for Tyrosine Kinase Inhibitors

Published:2013-01-09 Issue:1 Volume:8 Page:e53668
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Balabanov Stefan,Wilhelm Thomas,Venz Simone,Keller Gunhild,Scharf Christian,Pospisil Heike,Braig Melanie,Barett Christine,Bokemeyer Carsten,Walther Reinhard,Brümmendorf Tim H.,Schuppert Andreas

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference63 articles.

1. Mechanisms of drug inhibition of signalling molecules;JS Sebolt-Leopold;Nature,2006

2. Protein kinases [mdash] the major drug targets of the twenty-first century?;P Cohen;Nat Rev Drug Discov,2002

3. Issues and progress with protein kinase inhibitors for cancer treatment;J Dancey;Nat Rev Drug Discov,2003

4. The specificities of protein kinase inhibitors: an update;J Bain;The Biochemical journal,2003

5. A quantitative analysis of kinase inhibitor selectivity;MW Karaman;Nat Biotech,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethics, emerging research trends, issues and challenges;Anomaly Detection and Complex Event Processing over IoT Data Streams;2022

2. From hype to reality: data science enabling personalized medicine;BMC Medicine;2018-08-27

3. Overview on Anticancer Drug Design and Development;Current Medicinal Chemistry;2018-05-07

4. Toward Commercialization;Drug Delivery;2016-09-14

5. Systems Medicine in Pharmaceutical Research and Development;Methods in Molecular Biology;2016